$0.488 0.0 0.0%
Last Trade - 01/04/21
| Market Cap | £23.1m |
| Enterprise Value | £-566k |
| Revenue | £7.04m |
| Position in Universe | 5906th / 6850 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 10.2 | 7.82 | 6.37 | 6.55 | 9.28 | 9.93 | -0.6% | ||||
| +6,050 | +178.9 | +7.4 | ||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
China Health Industries Holdings, Inc. is a manufacturer of health food products. The Company's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The Company has three operating segments: Humankind, HLJ Huimeijia and others. Humankind is engaged in the manufacturing and sale of health products. HLJ Huimeijia is engaged in the manufacturing and distribution of tincture; ointments; rubber paste, including hormones; topical solution, suppositories, liniment, including traditional Chinese medicine extractions; enemas, and oral liquids. As of June 30, 2016, the Company, through Humankind manufactured and sold 14 health supplement products. As of June 30, 2016, the Company, through HLJ Huimeijia manufactured and sold 21 products. The Company's products are sold through sales agents.
| Last Annual | June 30th, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | August 19, 2004 |
| Public Since | December 1, 2004 |
| No. of Shareholders: | 501 |
| No. of Employees: | 96 |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 65,539,737 |
| Free Float | (0.0%) |
| Eligible for |
×
ISAs
✓
SIPPs
|
| Address | 3199-1 Longxiang Road,Songbei District Harbin City, HAERBIN, 150028, China |
| Web | http://www.chinahealthindustries.com/ |
| Phone | +86 451 88100688 |
| Contact | Melody Zhang (Investor Relations) |
| Auditors | Centurion ZD CPA & Co. |
As of 01/04/21, shares in China Health Industries Holdings Inc are trading at $0.488, giving the company a market capitalisation of £23.1m. This share price information is delayed by 15 minutes.
Shares in China Health Industries Holdings Inc are currently trading at $0.488 and the price has moved by 35.25% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the China Health Industries Holdings Inc price has moved by -8.98% over the past year.
There are no analysts currently covering China Health Industries Holdings Inc.
China Health Industries Holdings Inc is scheduled to issue upcoming financial results on the following dates:
China Health Industries Holdings Inc does not currently pay a dividend.
China Health Industries Holdings Inc does not currently pay a dividend.
China Health Industries Holdings Inc does not currently pay a dividend.
To buy shares in China Health Industries Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in China Health Industries Holdings Inc are currently trading at $0.488, giving the company a market capitalisation of £23.1m.
Here are the trading details for China Health Industries Holdings Inc:
Based on an overall assessment of its quality, value and momentum, China Health Industries Holdings Inc is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for China Health Industries Holdings Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Health Industries Holdings Inc. Over the past six months, the relative strength of its shares against the market has been 13.84%. At the current price of $0.488, shares in China Health Industries Holdings Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The China Health Industries Holdings Inc PE ratio based on its reported earnings over the past 12 months is 12.01. The shares are currently trading at $0.488.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
China Health Industries Holdings Inc's management team is headed by:
Here are the top five shareholders of China Health Industries Holdings Inc based on the size of their shareholding:
